BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 12849327)

  • 1. Dyskinesias after transplantation in Parkinson's disease.
    Piccini P
    Lancet Neurol; 2002 Dec; 1(8):472. PubMed ID: 12849327
    [No Abstract]   [Full Text] [Related]  

  • 2. Neural transplantation for the treatment of Parkinson's disease.
    Björklund A; Dunnett SB; Brundin P; Stoessl AJ; Freed CR; Breeze RE; Levivier M; Peschanski M; Studer L; Barker R
    Lancet Neurol; 2003 Jul; 2(7):437-45. PubMed ID: 12849125
    [No Abstract]   [Full Text] [Related]  

  • 3. Graft-induced dyskinesias fail to respond to 5HT1A agonist in the long-term.
    Beaulieu-Boire I; Fasano A
    Mov Disord; 2015 May; 30(6):872-3. PubMed ID: 25758209
    [No Abstract]   [Full Text] [Related]  

  • 4. Graft-induced dyskinesias in Parkinson's disease: what is it all about?
    Barker RA; Kuan WL
    Cell Stem Cell; 2010 Aug; 7(2):148-9. PubMed ID: 20682443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parkinson's transplant therapy faces setback.
    Check E
    Nature; 2003 Aug; 424(6952):987. PubMed ID: 12944933
    [No Abstract]   [Full Text] [Related]  

  • 6. Cellular replacement therapy for Parkinson's disease--where we are today?
    Redmond DE
    Neuroscientist; 2002 Oct; 8(5):457-88. PubMed ID: 12374430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dyskinesias following neural transplantation in Parkinson's disease.
    Hagell P; Piccini P; Björklund A; Brundin P; Rehncrona S; Widner H; Crabb L; Pavese N; Oertel WH; Quinn N; Brooks DJ; Lindvall O
    Nat Neurosci; 2002 Jul; 5(7):627-8. PubMed ID: 12042822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease.
    Olanow CW; Goetz CG; Kordower JH; Stoessl AJ; Sossi V; Brin MF; Shannon KM; Nauert GM; Perl DP; Godbold J; Freeman TB
    Ann Neurol; 2003 Sep; 54(3):403-14. PubMed ID: 12953276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Focal not widespread grafts induce novel dyskinetic behavior in parkinsonian rats.
    Maries E; Kordower JH; Chu Y; Collier TJ; Sortwell CE; Olaru E; Shannon K; Steece-Collier K
    Neurobiol Dis; 2006 Jan; 21(1):165-80. PubMed ID: 16095907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trials offer way forward for Parkinson's.
    Abbott A
    Nature; 2001 Mar; 410(6827):401. PubMed ID: 11260676
    [No Abstract]   [Full Text] [Related]  

  • 11. Transplantation of embryonic dopamine neurons for severe Parkinson's disease.
    Freed CR; Greene PE; Breeze RE; Tsai WY; DuMouchel W; Kao R; Dillon S; Winfield H; Culver S; Trojanowski JQ; Eidelberg D; Fahn S
    N Engl J Med; 2001 Mar; 344(10):710-9. PubMed ID: 11236774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cell therapy for Parkinson's disease].
    Morizane A; Takahashi J
    Nihon Yakurigaku Zasshi; 2016 May; 147(5):264-8. PubMed ID: 27181719
    [No Abstract]   [Full Text] [Related]  

  • 13. Parkinson's patients show positive response to implants.
    Check E
    Nature; 2002 Apr; 416(6882):666. PubMed ID: 11961513
    [No Abstract]   [Full Text] [Related]  

  • 14. Neural transplantation (auto-adrenal, fetal nigral and fetal adrenal) in Parkinson's disease: the Mexican experience.
    Madrazo I; Franco-Bourland R; Ostrosky-Solis F; Aguilera M; Cuevas C; Alvarez F; Magallon E; Zamorano C; Morelos A
    Prog Brain Res; 1990; 82():593-602. PubMed ID: 1981281
    [No Abstract]   [Full Text] [Related]  

  • 15. The future of cell therapies in the treatment of Parkinson's disease.
    Laguna Goya R; Kuan WL; Barker RA
    Expert Opin Biol Ther; 2007 Oct; 7(10):1487-98. PubMed ID: 17916042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fatal cyst formation after fetal mesencephalic allograft transplant for Parkinson's disease.
    Mamelak AN; Eggerding FA; Oh DS; Wilson E; Davis RL; Spitzer R; Hay JA; Caton WL
    J Neurosurg; 1998 Oct; 89(4):592-8. PubMed ID: 9761053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term outcome of unilaterally transplanted parkinsonian patients. I. Clinical approach.
    Defer GL; Geny C; Ricolfi F; Fenelon G; Monfort JC; Remy P; Villafane G; Jeny R; Samson Y; Keravel Y; Gaston A; Degos JD; Peschanski M; Cesaro P; Nguyen JP
    Brain; 1996 Feb; 119 ( Pt 1)():41-50. PubMed ID: 8624693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Graft placement and uneven pattern of reinnervation in the striatum is important for development of graft-induced dyskinesia.
    Carlsson T; Winkler C; Lundblad M; Cenci MA; Björklund A; Kirik D
    Neurobiol Dis; 2006 Mar; 21(3):657-68. PubMed ID: 16256359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brain imaging after neural transplantation.
    Politis M; Piccini P
    Prog Brain Res; 2010; 184():193-203. PubMed ID: 20887876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for long-term survival and function of dopaminergic grafts in progressive Parkinson's disease.
    Lindvall O; Sawle G; Widner H; Rothwell JC; Björklund A; Brooks D; Brundin P; Frackowiak R; Marsden CD; Odin P
    Ann Neurol; 1994 Feb; 35(2):172-80. PubMed ID: 8109898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.